Citadel Advisors - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is and the CUSIP is 98973P901. A total of 2 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q2 2016$349,000
-39.8%
63,600
-18.6%
0.00%
-100.0%
Q1 2016$580,000
+79.6%
78,100
+100.8%
0.00%
Q4 2015$323,000
-55.4%
38,900
-51.6%
0.00%
-100.0%
Q3 2015$724,000
-14.4%
80,400
+14.0%
0.00%0.0%
Q2 2015$846,000
+42.7%
70,500
+27.9%
0.00%0.0%
Q1 2015$593,000
+537.6%
55,100
+199.5%
0.00%
Q4 2014$93,000
+830.0%
18,400
+371.8%
0.00%
Q3 2014$10,000
-83.9%
3,900
-74.7%
0.00%
Q2 2014$62,000
-41.5%
15,400
-33.6%
0.00%
Q1 2014$106,000
-41.8%
23,200
-44.6%
0.00%
Q4 2013$182,000
+73.3%
41,900
+57.5%
0.00%
Q3 2013$105,000
+22.1%
26,600
-34.8%
0.00%
Q2 2013$86,00040,8000.00%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q3 2014
NameSharesValueWeighting ↓
SIMPLEX TRADING, LLC 257,300$330.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 91,400$12,0420.00%
View complete list of ZIOPHARM ONCOLOGY INC shareholders